Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor and epidermal growth factor.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  European Urology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000475232PMID 7750532
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Androgen receptor alterations in prostatic carcinoma

  1994cited by this paper
• Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators.

  1993cited by this paper
• Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone.

  1993cited by this paper
• Insulin‐like growth factor I: Action and receptor characterization in human prostate cancer cell lines

  1993cited by this paper
• Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I.

  1993cited by this paper
• Hormonal regulation of prostate‐specific antigen (PSA) glycoprotein in the human prostatic adenocarcinoma cell line, LNCaP

  1992cited by this paper
• Heparin-binding keratinocyte growth factor is a candidate stromal-to-epithelial-cell andromedin.

  1992cited by this paper
• Dopaminergic and ligand-independent activation of steroid hormone receptors.

  1991cited by this paper
• Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins in primary cultures of prostate epithelial cells.

  1991cited by this paper
• A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens.

  1990cited by this paper
• Regulation of growth and epidermal growth factor receptor levels of LNCaP prostate tumor cells by different steroids

  1988cited by this paper

• Sex hormone-psoriasis interactions: from sex-specific clinical features to immunoregulatory mechanisms.

  2026cites this paper
• ChIP happens: from biochemical origins to the modern omics toolbox for understanding steroid hormone receptors

  2026cites this paper
• Interactions between androgen and IGF1 axes in prostate tumorigenesis

  2024influential citation
• Paxillin regulates androgen receptor expression associated with granulosa cell focal adhesions

  2024cites this paper
• Inflammation impacts androgen receptor signaling in basal prostate stem cells through interleukin 1 receptor antagonist

  2024cites this paper
• Unveiling hormone‐stimulated gene mechanisms in prostate cancer: A prognostic model, immune infiltration analysis, and drug sensitivity study

  2024cites this paper
• Application of Original Prostate Cancer Progression Model Interacting with Fibroblasts in Preclinical Research

  2024cites this paper
• The androgen receptor in bladder cancer

  2023cites this paper
• Castration-Resistant Prostate Cancer: From Uncovered Resistance Mechanisms to Current Treatments

  2023cites this paper
• Emerging frontiers in nanomedicine targeted therapy for prostate cancer.

  2023cites this paper
• Exercise Mediates Myokine Release and Tumor Suppression in Prostate Cancer Independent of Androgen Signaling

  2023cites this paper
• Chronic Glucocorticoid Use and Risk for Advanced Prostate Cancer at Presentation: A SEER-Medicare Cohort Study.

  2023cites this paper
• Combined Therapies with Taxane-Based Chemotherapeutic Drugs in Prostate Cancer: Novel Insights and Future Directions

  2023cites this paper
• From Therapy Resistance to Targeted Therapies in Prostate Cancer

  2022cites this paper
• Resistance to prostate cancer treatments

  2022cites this paper
• The Extracellular Matrix Stiffening: A Trigger of Prostate Cancer Progression and Castration Resistance?

  2022cites this paper
• The androgen receptor messenger RNA: what do we know?

  2022cites this paper
• Estrogen Receptor-α Targeting: PROTACs, SNIPERs, Peptide-PROTACs, Antibody Conjugated PROTACs and SNIPERs

  2022cites this paper
• The mechanism of the cytotoxic effect of Panax notoginseng extracts on prostate cancer cells.

  2022cites this paper
• Spatio-temporal analysis of prostate tumors in situ suggests pre-existence of treatment-resistant clones

  2022cites this paper
• The Crosstalk of Long Non-Coding RNA and MicroRNA in Castration-Resistant and Neuroendocrine Prostate Cancer: Their Interaction and Clinical Importance

  2021cites this paper
• Preclinical Models in Prostate Cancer: Resistance to AR Targeting Therapies in Prostate Cancer

  2021cites this paper
• Undesirable Status of Prostate Cancer Cells after Intensive Inhibition of AR Signaling: Post-AR Era of CRPC Treatment

  2021cites this paper
• Role of PI3K-AKT-mTOR Pathway as a Pro-Survival Signaling and Resistance-Mediating Mechanism to Therapy of Prostate Cancer

  2021cites this paper
• Androgen Receptor Activation in Glioblastoma Can Be Achieved by Ligand-Independent Signaling through EGFR—A Potential Therapeutic Target

  2021cites this paper
• The Pathogenesis of Prostate Cancer

  2021influential citation
• MicroRNAs as Epigenetic Determinants of Treatment Response and Potential Therapeutic Targets in Prostate Cancer

  2021cites this paper
• MAPK4 promotes prostate cancer by concerted activation of androgen receptor and AKT.

  2021cites this paper
• Non-Coding RNAs Set a New Phenotypic Frontier in Prostate Cancer Metastasis and Resistance

  2021cites this paper
• A Review of the Pathophysiological Mechanisms Underlying Castration-resistant Prostate Cancer

  2021cites this paper
• Selective targeting of the androgen receptor-DNA binding domain by the novel antiandrogen SBF-1 and inhibition of the growth of prostate cancer cells

  2021cites this paper
• The metastasis suppressor NDRG1 directly regulates androgen receptor signaling in prostate cancer

  2021cites this paper
• Ameliorative effect of Abeliophyllum distichum Nakai on benign prostatic hyperplasia in vitro and in vivo

  2021influential citation
• Exploration and Biological Evaluation of Basic Heteromonocyclic Propanamide Derivatives as SARDs for the Treatment of Enzalutamide-Resistant Prostate Cancer.

  2021cites this paper
• Curcumin: a phytochemical modulator of estrogens and androgens in tumors of the reproductive system.

  2020cites this paper
• Pleiotropic Mechanisms Drive Endocrine Resistance in the Three-Dimensional Bone Microenvironment

  2020cites this paper
• Pyrazol-1-yl-propanamides as SARD and Pan-Antagonists for the Treatment of Enzalutamide-Resistant Prostate Cancer.

  2020cites this paper
• Treatment and resistance mechanisms in castration-resistant prostate cancer: new implications for clinical decision making?

  2020cites this paper
• The role of insulin-like growth factors in the development of prostate cancer

  2020cites this paper
• More Than Androgens: Hormonal and Paracrine Signaling in Prostate Development and Homeostasis

  2020cites this paper
• Neddylation inactivation represses androgen receptor transcription and inhibits growth, survival and invasion of prostate cancer cells

  2020cites this paper
• An androgen-independent mechanism underlying the androgenic effects of 3-methylcholanthrene, a potent aryl hydrocarbon receptor agonist.

  2020cites this paper
• Obesity, Inflammation, and Advanced Prostate Cancer

  2020influential citation
• Combinatorial Drug Therapy with Phytochemicals as Adjuvants in Prostate Cancer Management

  2019cites this paper
• Androgen Receptor Signaling in the Development of Castration-Resistant Prostate Cancer

  2019cites this paper
• Loss of Fibroblast-Dependent Androgen Receptor Activation in Prostate Cancer Cells is Involved in the Mechanism of Acquired Resistance to Castration

  2019cites this paper
• TRAF6 function as a novel co-regulator of Wnt3a target genes in prostate cancer

  2019cites this paper
• A human-derived prostate co-culture microtissue model using epithelial (RWPE-1) and stromal (WPMY-1) cell lines.

  2019cites this paper
• GPRC5A facilitates cell proliferation through cell cycle regulation and correlates with bone metastasis in prostate cancer

  2019cites this paper
• Focal Adhesion Kinase and β‐Catenin Cooperate to Induce Hepatocellular Carcinoma

  2019cites this paper
• Enhancement of androgen transcriptional activation assay based on genome edited glucocorticoid knock out human prostate cancer cell line

  2019cites this paper
• The Role of Platelets in Tumor Growth, Metastasis, and Immune Evasion

  2019cites this paper
• A magic drug target: Androgen receptor

  2019cites this paper
• Nuclear action of FGF members in endocrine-related tissues and cancer: Interplay with steroid receptor pathways.

  2019cites this paper
• Preclinical study using androgen receptor (AR) degradation enhancer to increase radiotherapy efficacy via targeting radiation-increased AR to better suppress prostate cancer progression

  2019cites this paper
• MiR-133a-5p inhibits androgen receptor (AR)-induced proliferation in prostate cancer cells via targeting FUsed in Sarcoma (FUS) and AR

  2019cites this paper
• Therapies Targeted to Androgen Receptor Signaling Axis in Prostate Cancer: Progress, Challenges, and Hope

  2019cites this paper
• Analyse protéomique des réseaux de signalisation du récepteur aux androgènes modulés par l'Enzalutamide dans le cancer de la prostate résistant à la castration

  2019cites this paper
• Role of Stromal Paracrine Signals in Proliferative Diseases of the Aging Human Prostate

  2018cites this paper
• Crosstalk Between Androgen-sensitive and Androgen-insensitive Prostate Cancer Cells.

  2018cites this paper
• Selective Androgen Receptor Modulator S42 Suppresses Prostate Cancer Cell Proliferation

  2018cites this paper
• Importance de la co-dérégulation des voies RAS/MAPK et PI3K/AKT/mTOR dans la transformation épithéliale prostatique. Approche in vivo à l'aide d'un modèle dans les glandes accessoires de la Drosophile

  2018cites this paper
• The Role of Androgen Receptor in Prostate Cancer

  2018cites this paper
• Interleukin‐6 induced overexpression of valosin‐containing protein (VCP)/p97 is associated with androgen‐independent prostate cancer (AIPC) progression

  2018cites this paper
• Over-Expression of Aryl Hydrocarbon Receptor (AhR) Enhances Src Kinase Activity to Functionally Induce AR Signaling and Promote Prostate Cancer Progression

  2018cites this paper
• Lysyl oxidase in cancer inhibition and metastasis.

  2018cites this paper
• New Insights in Prostate Cancer Development and Tumor Therapy: Modulation of Nuclear Receptors and the Specific Role of Liver X Receptors

  2018cites this paper
• Analysis of porcine body size variation using re-sequencing data of miniature and large pigs

  2018cites this paper
• A model of acquired resistance to the novel AR-NTD inhibitor ralaniten reveals resistance occurs via a selective metabolism pathway

  2018cites this paper
• Prostate Cancer Metabolism in the Interplay of Obesity and Estrogens Actions

  2018cites this paper
• Androgen action in prostate function and disease.

  2018cites this paper
• The function of oxytocin: a potential biomarker for prostate cancer diagnosis and promoter of prostate cancer

  2017cites this paper
• An androgen response element driven reporter assay for the detection of androgen receptor activity in prostate cells

  2017cites this paper
• Gene Polymorphism‐related Individual and Interracial Differences in the Outcomes of Androgen Deprivation Therapy for Prostate Cancer

  2017cites this paper
• Inhibition of the insulin-like growth factor-1 receptor potentiates acute effects of castration in a rat model for prostate cancer growth in bone

  2017cites this paper
• Prostate cancer xenografts and hormone induced prostate carcinogenesis.

  2017cites this paper
• A unifying biology of sex steroid-induced apoptosis in prostate and breast cancers

  2017cites this paper
• The role of inhibitor of apoptosis (IAP) family member survivin in prostatic disease

  2017cites this paper
• STAT3 in Prostate Cancer

  2017cites this paper
• Suppression of LIM and SH3 Domain Protein 1 (LASP1) Negatively Regulated by Androgen Receptor Delays Castration Resistant Prostate Cancer Progression

  2017cites this paper
• Mono-ubiquitination mediated regulation of KMT5A and its role in prostate cancer

  2017cites this paper
• Targeting MCT4 for treatment of advanced prostate cancers : inhibiting cell proliferation and enhancing anticancer immunity through suppressing lactic acid secretion and elevated glycolysis

  2017cites this paper
• [Effect of androgen receptor on IgG expression, proliferation and migration of prostate cancer cells in vitro].

  2017cites this paper
• 4.02 – Disorders of Sex Development in Males: Molecular Genetics, Epigenetics, Gender Identity, and Cognition

  2017cites this paper
• Identification of Mutations, Expression Alterations and Fusion Transcriptsby Next Generation RNAseq in Castration-Resistant Prostate Cancer Celllines with Possible Clinical Relevance

  2017cites this paper
• Epithelial-mesenchymal-transition regulators in prostate cancer: Androgens and beyond.

  2017cites this paper
• Dissecting major signaling pathways in prostate cancer development and progression: Mechanisms and novel therapeutic targets.

  2017cites this paper
• Mechanisms of Therapeutic Resistance in Prostate Cancer

  2017cites this paper
• The “ins and outs” of prostate metabolism towards carcinogenesis: the case of methoxychlor

  2017cites this paper
• Androgen–glucocorticoid interactions in the era of novel prostate cancer therapy

  2016cites this paper
• Targeting the androgen receptor in metastatic castrate-resistant prostate cancer: A review.

  2016cites this paper
• Chapter 143 – Endocrinology of Benign Prostatic Hyperplasia and Prostate Cancer

  2016cites this paper
• Bioactive natural products for chemoprevention and treatment of castration-resistant prostate cancer.

  2016cites this paper
• Targeting the N-Terminal Domain of the Androgen Receptor: A New Approach for the Treatment of Advanced Prostate Cancer

  2016cites this paper
• A single-center experience with abiraterone as treatment for metastatic castration-resistant prostate cancer.

  2016cites this paper
• Current perspectives between metabolic syndrome and cancer

  2016cites this paper
• Design And Synthesis Of Enzalutamide-Isothiocyanate Hybrid Drug As Anti-Prostate Cancer Agent

  2016cites this paper
• Epidermal growth factor induces p38 MAPK-dependent G0/G1-to-S transition in prostate cancer cells upon androgen deprivation conditions

  2016cites this paper
• Androgen receptor-dependent and -independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles

  2016cites this paper
• Differential expression of miR-34b and androgen receptor pathway regulate prostate cancer aggressiveness between African-Americans and Caucasians

  2016cites this paper